Ophthalmic Sutures Market size is anticipated to reach USD 1.6 billion by 2032, as per a new research report announced by Global Market Insights Inc.
Increasing occurrences of eye diseases leading to vision impairment is fostering the expansion for ophthalmic sutures. As per the WHO, currently, around 2 billion people suffer from distance or near vision impairment, which includes cataracts (94 million), refractive error (88.4 million), glaucoma (7.7 million), diabetic eye disease (3.9 million), and age-related macular degeneration (8 million), among others. The cost of productivity losses associated with vision impairment is projected to be nearly USD 400 billion.
Subsequently, eye surgeries are being widely adopted to address common vision problems, including hyperopia, astigmatism, and/or myopia. These surgeries can effectively address various eye conditions such as detached retinas, glaucoma, and diabetic retinopathy among others. Ophthalmic sutures play a vital role in postoperative care by ensuring good long-term healing and adequate closure depending on the type of incisions.
Browse key industry insights spread across 210 pages with 403 market data tables & 20 figures & charts from the report, “Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament/Braided) By Absorption (Absorbable, Non-absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy, Iridectomy, Oculoplastic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers [ASCs]), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2023 – 2032” in detail along with the table of contents:
High tensile strength to drive synthetic sutures segment
Ophthalmic sutures market revenue from synthetic sutures segment to hit over USD 1.1 billion in by 2032, owing to the growing development and awareness about the advantages offered by synthetic ophthalmic sutures. These sutures can be produced under precisely controlled manufacturing conditions and show more reliable strength than natural sutures. They are also capable of keeping their tensile strength for longer and their main purpose includes suturing of internal tissues and general soft-tissue approximation. Owing to their high flexibility level, they are preferred by an ophthalmologist.
Furthermore, the durability and cost-effectiveness of non-absorbable synthetic sutures favour their adoption. Synthetic absorbable sutures have also been FDA-approved for almost all surgical uses except certain neurological and cardiovascular surgeries in which nonabsorbable sutures are compulsory. The segment expansion can also be ascribed to the high tensile strength of synthetic sutures that ensures wound security. They have also improved over the last couple of years due to constant technological and scientific advancements.
Growing awareness about the benefits of ophthalmic sutures to bolster uncoated segment
Rising product demand and growing awareness about the benefits offered by ophthalmic sutures in surgeries to fuel the ophthalmic sutures market. Uncoated sutures are typically used for the desired apposition of wound edges, fixation of detached structures, lifting of tissues, and hanging back of tissues, among others.
Uncoated sutures can be braided or monofilament, permanent or dissolvable, and made from polypropylene, nylon, silk, or other material. Additionally, nylon sutures have low antigenicity, high elasticity, and can retain tensile strength for longer.
Increasing eye disease screening initiatives to impel the hospitals end-use segment
Ophthalmic sutures market from the hospitals segment to cross USD 965 million by 2032, driven by the rising number of ophthalmologists in developed economies. The industry progression is driven by robust healthcare infrastructure.
The segment growth can also be attributed to the increasing hospital admissions for ophthalmic surgeries and eye disease screening programs and initiatives along with the availability of highly skilled healthcare professionals. Increasing patient preference for hospitals can be credited to the use of novel surgical sutures in hospital settings. Moreover, the accessibility to better diagnosis and treatment coupled with the growing number of ophthalmic surgeries are augmenting segment outlook.
Strong demand for advanced surgical sutures to fuel North America ophthalmic sutures market progress
North America ophthalmic sutures industry value is set to grow over USD 575 million in by 2032, fueled by the growing incidence rate of diabetes in the region. The industry growth is driven by a multitude of factors including the increasing adoption of advanced surgical sutures, and the surging geriatric population across the region.
Product innovations to outline the ophthalmic sutures industry competitive scenario
Some leading players in the ophthalmic sutures market include Aurolab, Teleflex Incorporated, Ethicon (J&J), DemeTECH Corporation, and B Braun Melsungen AG, among others.